Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and stabilizing BAG3

Key Points

• Pancreatic ductal adenocarcinoma progression is driven by STAMBP's activity on BAG3, enhancing stability.
• Findings indicate that STAMBP facilitates deubiquitination of BAG3, contributing to cancer advancement.
• The analysis employed phosphorylation-dependent mechanisms to understand the role of STAMBP in cancer biology.
• These insights may enable targeted therapies focusing on the STAMBP-BAG3 interaction for pancreatic cancer treatment.